HUP0203315A2 - Eljárás pikonavírus ellenes hatású izoxazolkarboxamid-származékok előállítására és intermedier vegyületeik - Google Patents

Eljárás pikonavírus ellenes hatású izoxazolkarboxamid-származékok előállítására és intermedier vegyületeik

Info

Publication number
HUP0203315A2
HUP0203315A2 HU0203315A HUP0203315A HUP0203315A2 HU P0203315 A2 HUP0203315 A2 HU P0203315A2 HU 0203315 A HU0203315 A HU 0203315A HU P0203315 A HUP0203315 A HU P0203315A HU P0203315 A2 HUP0203315 A2 HU P0203315A2
Authority
HU
Hungary
Prior art keywords
group
nr21r22
general formula
formula
hydrogen atom
Prior art date
Application number
HU0203315A
Other languages
English (en)
Inventor
Srinivasan Babu
Raymond Dagnino
Kevin Scott Mcgee
Terence Jarold Moran
Naresh K. Nayyar
Travis Paul Remarchuk
Junhua Tao
Qingping Tian
Original Assignee
Agouron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of HUP0203315A2 publication Critical patent/HUP0203315A2/hu
Publication of HUP0203315A3 publication Critical patent/HUP0203315A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00002—Chemical plants
    • B01J2219/00027—Process aspects
    • B01J2219/00033—Continuous processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00103—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor in a heat exchanger separate from the reactor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00162—Controlling or regulating processes controlling the pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00177—Controlling or regulating processes controlling the pH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A találmány tárgya javított eljárás (IA) általános képletűpikonavírus-ellenes szerek - elsősorban etil-3-{(5'-metilizoxazol- 3'-karbonil)-L-Valy(COCH2)-L-(4-F-Phe)-L-((S)-PirrolAla)}-E-propanoát,ennek analógjainak vagy gyógyászatilag elfogadható sóinak -előállítására. A találmány szerinti eljárást úgy végzik, hogy A)lépésben (IIA) általános képletű vegyületet állítanak elő, B) lépésbena (IIA) általános képletű vegyületet amid előállítási reakcióbanreagáltatják (III) általános képletű vegyülettel, ahol a képletekbenR1 jelentése hidrogénatom, fluoratom, alkilcsoport, OH, SH vagy O-alkil-csoport; R2 és R3 jelentése például egymástól függetlenülhidrogénatom; R4 jelentése (3) képletű csoport; R6 jelentésehidrogénatom, fluoratom, alkilcsoport, cikloalkilcsoport,heterocikloalkilcsoport, arilcsoport vagy heteroarilcsoport; R7 és R8jelentése egymástól függetlenül hidrogénatom, alkilcsoport,cikloalkilcsoport, heterocikloalkilcsoport, arilcsoport,heteroarilcsoport, -OR17, -SR17, -NR17R18, -NR19NR17R18 vagy -NR17OR18képletű csoport; R20 jelentése (4) képletű csoport; és Z és Z1jelentése egymástól függetlenül hidrogénatom, fluoratom, alkilcsoport,cikloalkilcsoport, heterocikloalkilcsoport, arilcsoport,heteroarilcsoport, -C(O)R21, -CO2R21, CN, -C(O)NR21R22, -C(O)NR21OR22,-C(S)R21, -C(S)NR21R22, -NO2, -SOR21, -SO2R21, -SO2NR21R22, -SO(NR21)(OR22), -SONR21, -SO3R21, -PO(OR21)2, -PO(R21)(R22), -PO(NR21R22)(OR23), -PO(NR21R22)(NR23R24), -C(O)NR21R22R23 vagy -C(S)NR21NR22R23; vagy Z1 és R1 vagy Z és Z1 a hozzájuk kapcsolódóatomokkal együtt cikloalkilcsoportot vagy heterocikloalkilcsoportotképez. A találmány tárgyát képezik ezen kívül a fenti vegyületekelőállítására alkalmas intermedierek is. Ó
HU0203315A 1999-08-24 2000-08-23 Process and intermediates for the preparation of isoxazolecaroxamides and analogues HUP0203315A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15036599P 1999-08-24 1999-08-24
PCT/US2000/023032 WO2001014576A2 (en) 1999-08-24 2000-08-23 Process and intermediates for the preparation of isoxazolecaroxamides and analogues

Publications (2)

Publication Number Publication Date
HUP0203315A2 true HUP0203315A2 (hu) 2003-02-28
HUP0203315A3 HUP0203315A3 (en) 2003-12-29

Family

ID=22534191

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203315A HUP0203315A3 (en) 1999-08-24 2000-08-23 Process and intermediates for the preparation of isoxazolecaroxamides and analogues

Country Status (15)

Country Link
EP (1) EP1206470A2 (hu)
JP (1) JP2003511350A (hu)
KR (1) KR20020030795A (hu)
CN (2) CN1157391C (hu)
AU (1) AU778062B2 (hu)
BR (1) BR0013323A (hu)
CA (1) CA2376509A1 (hu)
CZ (1) CZ2002634A3 (hu)
HK (1) HK1051363A1 (hu)
HU (1) HUP0203315A3 (hu)
IL (1) IL147862A0 (hu)
MX (1) MXPA02001947A (hu)
PL (1) PL357162A1 (hu)
WO (1) WO2001014576A2 (hu)
ZA (1) ZA200200506B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198838C (zh) 1998-04-30 2005-04-27 阿格罗尼制药公司 抗小rna病毒化合物及其制备方法和用途
ES2230135T3 (es) 1999-08-04 2005-05-01 Agouron Pharmaceuticals, Inc. Compuestos y composiciones anti-picornavirales; utilizaciones farmaceuticas y materiales utilizados para su sintesis.
US6774243B2 (en) 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PE20011277A1 (es) 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PL365470A1 (en) 2000-06-14 2005-01-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
DE10208007A1 (de) * 2002-02-26 2003-09-18 Forschungszentrum Juelich Gmbh Verfahren zur Herstellung von Alkoholen aus Substraten mittels Oxidoreduktasen, Zweiphasensystem umfassend eine wässrige Phase und eine organische Phase sowie Vorrichtung zur Durchführung des Verfahrens
CN106831657B (zh) * 2017-02-23 2019-07-16 江苏工程职业技术学院 一种环氧丙酸钾的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2426651C3 (de) * 1974-06-01 1982-04-08 Bayer Ag, 5090 Leverkusen (-)-Antipode des 3-(p-Chlorphenyl)-2-chlorpropionsäuremethylesters, Verfahren zu dessen Herstellung sowie dessen Verwendung als Herbizid
DE2930087A1 (de) * 1979-07-25 1981-02-26 Biotechnolog Forschung Gmbh Verfahren zur kontinuierlichen enzymatischen umwandlung von wasserloeslichen alpha -ketocarbonsaeuren in die entsprechenden alpha -hydroxycarbonsaeuren
JPH0623131B2 (ja) * 1984-08-07 1994-03-30 三井東圧化学株式会社 α−ケト酸のアルカリ金属塩の製造法
JPH066539B2 (ja) * 1986-03-14 1994-01-26 三共株式会社 α−ハイドロキシカルボン酸誘導体の製法
FR2686897B1 (fr) * 1992-02-05 1995-07-13 Sonertec Procede en continu de fabrication d'acides organiques.
US5360927A (en) * 1994-01-24 1994-11-01 Development Center For Biotechnology Process for the preparation of monohydrated sodium phenylpyruvate
US5869697A (en) * 1994-05-02 1999-02-09 Council Of Scientific & Industrial Research Process for preparing diltiazem

Also Published As

Publication number Publication date
CA2376509A1 (en) 2001-03-01
WO2001014576A3 (en) 2001-08-30
KR20020030795A (ko) 2002-04-25
EP1206470A2 (en) 2002-05-22
CZ2002634A3 (cs) 2002-09-11
WO2001014576A8 (en) 2002-06-20
WO2001014576B1 (en) 2001-09-27
CN1382139A (zh) 2002-11-27
PL357162A1 (en) 2004-07-26
CN1157391C (zh) 2004-07-14
WO2001014576A2 (en) 2001-03-01
CN1524960A (zh) 2004-09-01
MXPA02001947A (es) 2002-10-31
AU778062B2 (en) 2004-11-11
BR0013323A (pt) 2002-04-02
IL147862A0 (en) 2002-08-14
ZA200200506B (en) 2003-06-25
HUP0203315A3 (en) 2003-12-29
HK1051363A1 (en) 2003-08-01
JP2003511350A (ja) 2003-03-25
AU6797000A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
AU679859B2 (en) Novel compound, process for producing the same, and antitumor agent
NZ307505A (en) Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
DE69908546D1 (de) Imidazopyridinderivate und Verfahren zu ihrer Herstellung
HUP0203315A2 (hu) Eljárás pikonavírus ellenes hatású izoxazolkarboxamid-származékok előállítására és intermedier vegyületeik
DK0430201T3 (hu)
EP0997462A4 (en) NOVEL NAPHTHYRIDINE DERIVATIVES OR THEIR SALTS
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
EA200200611A1 (ru) Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции
IL147668A0 (en) A process for the preparation of venlafaxin
MY136065A (en) Prodrugs to nmda receptor ligands
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
ATE6500T1 (de) 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3 4-tetrahydronaphthalin, seine salze, und verfahren zu dessen herstellung.
HUT59930A (en) Process for producing bis-phosphonic acid derivatives and pharmaceutical compositions containing them as active component
DK0854135T3 (da) Fremgangsmåde til fremstilling af 2-cyanobiphenylforbindelser
HUT58273A (en) Process for producing aminoketon compounds and pharmaceutical compositions containing them
HUT60992A (en) Process for producing optically active norbornyl amine derivatives
ATE396975T1 (de) 5-aminopyrazol-4-carboxylat derivate und verfahren zu ihrer herstellung
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees